Jon R. Moeller
Chairman, President and CEO at The Procter & Gamble Company · b. 1964
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: The Procter & Gamble Company, 3 years.
Chief executive roles
Mixed · grade D
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 50% of the scoring weight is on file.
- Dividends 15%
- 70
- Revenue growth 20%
- 52
- Earnings growth 15%
- 55
dividend grew 5.6% a year
2.7% a year in revenue
3.8% a year in earnings per share
50% of the scoring weight is on file. Figures cover June 2021 – June 2026.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Eli Lilly and Company May 4, 202698.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | The Procter & Gamble Company | Option exercise | +162,232 | $113.23 | $18,369,529 |
| Feb 12, 2026 | The Procter & Gamble Company | Open-market sale | −162,232 | $162.45 | $26,354,588 |
| Feb 11, 2026 | The Procter & Gamble Company | Option exercise | +11,036 | $113.23 | $1,249,606 |
| Feb 11, 2026 | The Procter & Gamble Company | Open-market sale | −11,036 | $160.00 | $1,765,760 |
| Dec 3, 2025 | The Procter & Gamble Company | Shares withheld for tax | −719 | $144.35 | $103,798 |
| Dec 3, 2025 | The Procter & Gamble Company | Option exercise | +159 | $144.35 | $22,972 |
| Dec 3, 2025 | The Procter & Gamble Company | Shares withheld for tax | −159 | $144.35 | $22,972 |
| Dec 3, 2025 | The Procter & Gamble Company | Shares withheld for tax | −151 | $144.35 | $21,808 |
| Nov 17, 2025 | Eli Lilly and Company | Grant or award | +233 | $1,021.70 | $238,332 |
| Oct 2, 2025 | The Procter & Gamble Company | Open-market sale | −11,684 | $152.23 | $1,778,655 |
| Oct 1, 2025 | The Procter & Gamble Company | Grant or award | +12,241 | — | — |
| Aug 19, 2025 | The Procter & Gamble Company | Open-market sale | −40,119 | $157.27 | $6,309,515 |
| Aug 18, 2025 | The Procter & Gamble Company | Grant or award | +89,970 | — | — |
| Dec 19, 2024 | The Procter & Gamble Company | Option exercise | +139 | $169.79 | $23,570 |
| Dec 19, 2024 | The Procter & Gamble Company | Shares withheld for tax | −139 | $169.79 | $23,570 |
Questions about Jon R. Moeller
What boards is Jon R. Moeller on?
Jon R. Moeller sits on the boards of Eli Lilly and Company and The Procter & Gamble Company.
What company is Jon R. Moeller the CEO of?
Jon R. Moeller has been Chairman, President and CEO of The Procter & Gamble Company since November 2021.
How long has Jon R. Moeller served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.